Medicure MCUJF
OTC MCUJF
$1.95 +0.09 (+4.84%)
At close: Sep 28, 2026 · 4:00 PM EDT

Medicure (MCUJF) Cash from Restructuring (2022)

Updated

Medicure (MCUJF) recorded Cash from Restructuring of -$32,415 in the quarter ended Dec 31, 2022.

Analysis

Medicure (MCUJF) Cash from Restructuring (2022) Analysis & Trends

For the year ended Dec 31, 2022, Medicure reported Cash from Restructuring of -$266,131.

  • Across earlier years, Cash from Restructuring came in at -$1.44 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Medicure 203.51 Mn 195.32 Mn 2.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -32,414.93
API Access

Medicure Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=MCUJF&period=max&api_key=YOUR_API_KEY